Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113234696A reveals high-purity in vitro crocetin production. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112437813A reveals a one-step enzymatic NAD synthesis. This method significantly lowers production costs and simplifies supply chains for global buyers.
Patent CN116287051B reveals a novel one-pot enzymatic route for Thienodolin. Discover cost-effective biosynthesis strategies for high-purity plant growth regulators.
Discover the patented enzymatic method for producing stable Vitamin C-2-phosphate. Achieve superior purity and yield for feed and pharma applications with scalable biocatalysis.
Patent CN120290522A reveals high-efficiency pyridoxal kinase mutants for vitamin manufacturing. Achieve lower costs and scalable supply chain reliability today.
Patent CN114277020B reveals a novel nitrilase mutant for phenylacetic acid synthesis. This report analyzes cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN106801043B reveals high-efficiency enzymatic synthesis for Sitagliptin intermediates, offering superior purity and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN106047950A details enzymatic reduction for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN106995807B reveals high-activity transaminase for Sitagliptin. Enables cost reduction in pharmaceutical intermediates manufacturing with superior enantioselectivity.
Novel engineered ketoreductase enables high optical purity synthesis of chiral intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel enzyme mutant enables high-purity drug intermediate synthesis with improved conversion rates and industrial scalability for global supply chains.
Patent CN107653238B reveals immobilized biocatalysis for statin intermediates. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable solutions.
Patent CN112501223B details a one-step enzymatic route for statin side chains, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN120574796A enables high-purity (S)-nornicotine production. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN1592788A reveals non-GMO bioconversion for alpha-ketobutyrate. Enhances supply chain safety and reduces chemical synthesis costs for flavor manufacturers.
Patent CN115341009B details enzyme solution reuse for steroid synthesis. Reduces cost and improves yield for pharmaceutical intermediates manufacturing supply chains.
Patent CN116024284A reveals mutant imine reductase for S-nicotine. Achieve >99% ee and high conversion. Reliable pharmaceutical intermediate supplier for cost reduction.
Patent CN119040289B enables high-purity chiral amine production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN118064513A reveals a novel biocatalytic route for high-purity acetyl hydroxyproline. This method offers significant cost reduction and supply chain reliability for cosmetic manufacturers.
Novel acetamidase mutant enables high-purity chiral acid production. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.